Lukas Hainz

The assumption that digital health applications safeguard the most intimate aspects of human biology has been fundamentally challenged by a recent investigation into the practices of major femtech platforms. Mozilla’s "Privacy Not Included" research team recently uncovered a significant breach of

The pharmaceutical landscape across the African continent has long been defined by a precarious reliance on external suppliers, but Natco Pharma is currently challenging this status quo with a decisive two hundred and sixty million dollar investment into the South African medical infrastructure.

James Maitland stands at the forefront of the intersection between medical robotics and the Internet of Things, bringing a visionary perspective to how we monitor and maintain the human body. With a career dedicated to developing high-fidelity sensors and integrated healthcare systems, he has

The pharmaceutical industry has long grappled with a massive disconnect between the rapid pace of computational drug discovery and the often-stagnant timelines of physical manufacturing and distribution. In a move designed to bridge this gap, Insilico Medicine and Bora Pharmaceuticals have entered

Behind the sterile hallways and glowing monitors of modern hospitals, a silent digital revolution is taking place that many healthcare administrators are only beginning to recognize as a profound systemic vulnerability. While executive boards prioritize the implementation of high-end imaging

The landscape of neurological research underwent a fundamental transformation with the publication of the 2024 McDonald Criteria in The Lancet Neurology, setting a new benchmark for diagnostic accuracy and speed. These updated standards replaced the long-standing 2017 framework, introducing a more

Families across the United States are encountering a disconcerting reality as local clinics fill with patients reporting severe respiratory distress while federal health dashboards remain stagnant. This rift between the lived experience of the American public and the official metrics provided by

The diagnosis of an aggressive glioblastoma in one of the world's leading pathological experts created an unprecedented opportunity to challenge established medical boundaries through self-experimentation. Professor Richard Scolyer, recognized globally for his pioneering work in melanoma, turned

The collision of high-stakes venture capital and federal healthcare policy has reached a fever pitch as the industry aggressively pivots away from archaic fee-for-service models toward tech-driven outcomes. Pearl Health recently secured a significant $110 million funding milestone, a strategic

The vast Australian landscape has traditionally presented a formidable challenge to the equitable distribution of specialized mental health services, leaving millions in remote regions underserved. For decades, the tyranny of distance meant that a resident in the Kimberley or the outback of